Enstilar Calcipotriol & Betamethasone Plaque Psoriasis Cutaneous Foam 60g

• Topical combination foam for moderate to severe plaque psoriasis • Contains calcipotriol 50mcg/g and betamethasone dipropionate 0.5mg/g • 60g pressurized canister for once-daily application • Suitable for adults with psoriasis on body and scalp • Dermatologically tested for skin tolerability

Enstilar Cutaneous Foam 60g is a dual-action topical treatment combining calcipotriol (vitamin D analogue) to normalize skin cell growth and betamethasone (potent corticosteroid) to reduce inflammation in plaque psoriasis. The aerosol foam formulation ensures better penetration and absorption compared to ointments, providing rapid itch relief and plaque clearance within 4 weeks in clinical trials. Suitable for up to 30% body surface area; not for face, flexures, or genitals. Flammable—keep away from flames. Manufactured by LEO Pharma; store below 25°C; discard 6 months after first use. Benefits • Clears psoriasis plaques faster with once-daily application • Reduces scaling, redness, and thickness effectively • Foam vehicle improves patient adherence and cosmetic acceptability • Rapid itch relief within days of starting treatment • Up to 4 weeks continuous use with low risk of skin atrophy How to Use • Shake canister well before use • Hold upside down; dispense small amount onto fingertip • Apply thin layer to affected areas once daily; gently rub in • Maximum 100g/week; treat for up to 4 weeks • Wash hands after application (unless treating hands) • Avoid eyes, mouth, and open wounds; do not cover with occlusive dressings